Carbon Dioxide Leaks Lead to A3/A5 Anesthesia Delivery System Recall

|

Reports of carbon dioxide leaks have led to a recall of Mindray anesthesia systems. 

The Mindray A3/A5 Anesthesia Delivery System recall was announced by the FDA on November 14, after the manufacturer received a report suggesting that the device may have a tendency to leak carbon dioxide (CO2). There have been no reports of injury or illness resulting from the defective anesthesia systems.

According to the recall announcement, the leaks are caused by improper seating of the CO2 absorbent canister gasket. When the gasket is improperly seated it will likely be detected during the system’s Automatic Circuit Leak and Compliance Test, which is performed at startup. It will also likely be detected during the Manual Leak Test, which the company recommends be conducted before each use. In these instances the canister can be unlocked and locked again to reseat the gasket, the company advises.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The company actually began notifying its customers individually of the problem in August and enacting repairs. However only 70% of the systems on the market have been repaired.

The recall affects the A3/A5 Anesthesia Delivery Systems shipped between May 31, 2011 and July 15, 2012 in the U.S., Australia and throughout Latin America. The affected units can be identified by a small “step” in the gasket surface.

Repairs are being conducted by Mindray Service or authorized representatives who replace the canister gasket.

Consumers with questions can contact the company by calling (800) 288-2121 ext. 5050.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.
A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL.
Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation.